Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Recursion Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 343 institutions reported holding Recursion Pharmaceuticals, Inc., 62.3% of its shares. Largest: Vanguard, BlackRock and ARK. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Recursion Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 63.3M | 10.2% | +5.12M | Nov 16, 2026 |
| BlackRock | 53.5M | 8.6% | +3.17M | Nov 13, 2026 |
| ARK | 44.7M | 7.2% | +3.41M | Nov 13, 2026 |
| State Street | 30M | 4.8% | −4.7M | Nov 12, 2026 |
| Baillie Gifford & Co | 18.2M | 2.9% | −5.31M | Nov 9, 2026 |
| Geode Capital | 13.9M | 2.2% | +94,706 | Nov 6, 2026 |
| Softbank Group Corp. | 13.6M | 2.2% | no change | Nov 16, 2026 |
| Fidelity | 11.4M | 1.8% | +11.4M | Nov 10, 2026 |
| UBS | 9.22M | 1.5% | −487K | Nov 16, 2026 |
| MIC Capital Management UK LLP | 8.26M | 1.3% | −1.39M | Nov 13, 2026 |